These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
303 related items for PubMed ID: 32011516
21. Clinical implications of conventional cytogenetics, fluorescence in situ hybridization (FISH) and molecular testing in chronic myeloid leukaemia patients in the tyrosine kinase inhibitor era - A review. Ankathil R, Ismail SM, Mohd Yunus N, Sulong S, Husin A, Abdullah AD, Hassan R. Malays J Pathol; 2020 Dec; 42(3):307-321. PubMed ID: 33361712 [Abstract] [Full Text] [Related]
25. Chronic myeloid leukemia blast crisis presented with AML of t(9;22) and t(3;14) mimicking acute lymphocytic leukemia. Liu K, Hu J, Wang X, Li L. J Clin Lab Anal; 2019 Oct; 33(8):e22961. PubMed ID: 31218758 [Abstract] [Full Text] [Related]
26. Factors influencing a second myeloid malignancy in patients with Philadelphia-negative -7 or del(7q) clones during tyrosine kinase inhibitor therapy for chronic myeloid leukemia. Groves MJ, Sales M, Baker L, Griffiths M, Pratt N, Tauro S. Cancer Genet; 2011 Jan; 204(1):39-44. PubMed ID: 21356190 [Abstract] [Full Text] [Related]
28. Impact of an Additional Chromosome on the Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Philadelphia Chromosome-Positive Acute Myeloid Leukemia in Adults. Min GJ, Kim HJ, Yoon JH, Kwak DH, Park SS, Jeon YW, Lee SE, Cho BS, Eom KS, Kim YJ, Lee S, Min CK, Cho SG, Kim DW, Lee JW, Min WS. Biol Blood Marrow Transplant; 2018 Aug; 24(8):1621-1628. PubMed ID: 29698793 [Abstract] [Full Text] [Related]
29. Ponatinib: A new tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia. Shamroe CL, Comeau JM. Ann Pharmacother; 2013 Nov; 47(11):1540-6. PubMed ID: 24265264 [Abstract] [Full Text] [Related]
30. Recurrent chronic myeloid leukemia with t (9;22;16) (q34; q11; p13) treated by nilotinib: A case report. Shu Y, Yang W, Zhang X, Xu X. Medicine (Baltimore); 2018 Oct; 97(42):e12875. PubMed ID: 30335005 [Abstract] [Full Text] [Related]
32. Transient presence of clonal chromosomal aberrations in Ph-negative cells in patients with chronic myeloid leukemia remaining in deep molecular response on tyrosine kinase inhibitor treatment. Gniot M, Lewandowski K, Ratajczak B, Lewandowska M, Lehmann-Kopydłowska A, Jarmuż-Szymczak M, Komarnicki M. Cancer Genet; 2014 Oct; 207(10-12):503-10. PubMed ID: 25496750 [Abstract] [Full Text] [Related]
33. [Development of Ph negative acute myeloid leukemia in a patient with minor-BCR/ABL positive chronic myeloid leukemia achieving a partial cytogenetic response during tyrosine kinase inhibitor treatment]. Fujii S, Miura I, Tanaka H. Rinsho Ketsueki; 2015 Jun; 56(6):681-6. PubMed ID: 26256879 [Abstract] [Full Text] [Related]
34. Gelatinous bone marrow transformation and emergence of clonal Philadelphia-negative cytogenetic abnormalities with excess blasts in a patient with chronic myeloid leukemia treated with dasatinib. Hermel DJ, Nael A, Lu YT, Kim J, Brynes RK, Vergara-Lluri M, Akhtari M. Anticancer Drugs; 2019 Apr; 30(4):416-421. PubMed ID: 30875349 [Abstract] [Full Text] [Related]
35. Rare monosomy 7 and deletion 7p at diagnosis of chronic myeloid leukemia in accelerated phase. Alswied A, Rehman A, Lai LW, Duran J, Sardar M, Proytcheva MA. Cancer Genet; 2021 Apr; 252-253():111-114. PubMed ID: 33497941 [Abstract] [Full Text] [Related]